RAFAEL HOLDINGS, INC. Debt Securities, Realized Gain (Loss)
RAFAEL HOLDINGS, INC. (RFL) reported Debt Securities, Realized Gain (Loss) of $178.00 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesRealizedGainLoss · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. debt securities, realized gain (loss) for the quarter ending 2025-07-31 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. debt securities, realized gain (loss) for the quarter ending 2025-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. debt securities, realized gain (loss) for the quarter ending 2025-01-31 was -$16.00K, a 104.01% decline year-over-year.
- RAFAEL HOLDINGS, INC. debt securities, realized gain (loss) for the quarter ending 2024-10-31 was $194.00K, a 9.60% increase year-over-year.
- RAFAEL HOLDINGS, INC. debt securities, realized gain (loss) for fiscal 2025 was $178.00K, a 89.95% decline from fiscal 2024.
- RAFAEL HOLDINGS, INC. debt securities, realized gain (loss) for fiscal 2024 was $1.77M, a 1050.65% increase from fiscal 2023.
- RAFAEL HOLDINGS, INC. debt securities, realized gain (loss) for fiscal 2023 was $154.00K.
| Period end | Debt Securities, Realized Gain (Loss) 3 month | Debt Securities, Realized Gain (Loss) 6 month | Debt Securities, Realized Gain (Loss) 9 month | Debt Securities, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2026-06-11 | -$16.00K derived: sum of 3 quarters · filed 2026-06-11 | $178.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$16.00K derived: sum of 2 quarters · filed 2026-06-11 | $178.00K 10-Q · filed 2026-06-11 | $429.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | -$16.00K 10-Q · filed 2026-03-16 | $178.00K 10-Q · filed 2026-03-16 | $429.00K derived: sum of 3 quarters · filed 2026-03-16 | $1.37M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | $194.00K 10-Q · filed 2025-12-12 | $445.00K derived: sum of 2 quarters · filed 2025-12-12 | $1.39M derived: sum of 3 quarters · filed 2025-12-12 | $1.79M derived: sum of 4 quarters · filed 2025-12-12 |
| 2024-07-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $1.20M derived: sum of 2 quarters · filed 2025-10-29 | $1.59M derived: sum of 3 quarters · filed 2025-10-29 | $1.77M 10-K · filed 2025-10-29 |
| 2024-04-30 | $945.00K 10-Q · filed 2025-06-11 | $1.34M derived: sum of 2 quarters · filed 2025-06-11 | $1.52M 10-Q · filed 2025-06-11 | $1.52M derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-01-31 | $399.00K 10-Q · filed 2025-03-14 | $576.00K 10-Q · filed 2025-03-14 | $576.00K derived: sum of 3 quarters · filed 2025-03-14 | |
| 2023-10-31 | $177.00K 10-Q · filed 2024-12-11 | $177.00K derived: sum of 2 quarters · filed 2024-12-20 | ||
| 2023-07-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $154.00K 10-K/A · filed 2024-12-20 | ||
| 2023-04-30 | $154.00K 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |